134 related articles for article (PubMed ID: 1569071)
1. The identification of O-glycosylated precursors of insulin-like growth factor II.
Hudgins WR; Hampton B; Burgess WH; Perdue JF
J Biol Chem; 1992 Apr; 267(12):8153-60. PubMed ID: 1569071
[TBL] [Abstract][Full Text] [Related]
2. The expression and characterization of human recombinant proinsulin-like growth factor II and a mutant that is defective in the O-glycosylation of its E domain.
Yang CQ; Zhan X; Hu X; Kondepudi A; Perdue JF
Endocrinology; 1996 Jul; 137(7):2766-73. PubMed ID: 8770896
[TBL] [Abstract][Full Text] [Related]
3. Characterization of O-glycosylated precursors of insulin-like growth factor II by matrix-assisted laser desorption/ionization mass spectrometry.
Jespersen S; Koedam JA; Hoogerbrugge CM; Tjaden UR; van der Greef J; Van den Brande JL
J Mass Spectrom; 1996 Aug; 31(8):893-900. PubMed ID: 8799315
[TBL] [Abstract][Full Text] [Related]
4. Biosynthesis of the insulin-like growth factor-II (IGF-II)/mannose-6-phosphate receptor in rat C6 glial cells: the role of N-linked glycosylation in binding of IGF-II to the receptor.
Kiess W; Greenstein LA; Lee L; Thomas C; Nissley SP
Mol Endocrinol; 1991 Feb; 5(2):281-91. PubMed ID: 1645456
[TBL] [Abstract][Full Text] [Related]
5. Serum "big insulin-like growth factor II" from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing.
Daughaday WH; Trivedi B; Baxter RC
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5823-7. PubMed ID: 7685912
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of an insulin-like growth factor II variant from human plasma.
Hampton B; Burgess WH; Marshak DR; Cullen KJ; Perdue JF
J Biol Chem; 1989 Nov; 264(32):19155-60. PubMed ID: 2553732
[TBL] [Abstract][Full Text] [Related]
7. Serum high molecular weight form of insulin-like growth factor II from patients with non-islet cell tumor hypoglycemia is O-glycosylated.
Hizuka N; Fukuda I; Takano K; Asakawa-Yasumoto K; Okubo Y; Demura H
J Clin Endocrinol Metab; 1998 Aug; 83(8):2875-7. PubMed ID: 9709962
[TBL] [Abstract][Full Text] [Related]
8. Characterization of truncated insulin-like growth factor-binding protein-2 in human milk.
Ho PJ; Baxter RC
Endocrinology; 1997 Sep; 138(9):3811-8. PubMed ID: 9275069
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-binding protein from human plasma. Purification and characterization.
Martin JL; Baxter RC
J Biol Chem; 1986 Jul; 261(19):8754-60. PubMed ID: 3722172
[TBL] [Abstract][Full Text] [Related]
10. Post-translational processing of the insulin-like growth factor-2 precursor. Analysis of O-glycosylation and endoproteolysis.
Duguay SJ; Jin Y; Stein J; Duguay AN; Gardner P; Steiner DF
J Biol Chem; 1998 Jul; 273(29):18443-51. PubMed ID: 9660813
[TBL] [Abstract][Full Text] [Related]
11. Purification and characterization of a unique high molecular weight form of insulin-like growth factor II.
Gowan LK; Hampton B; Hill DJ; Schlueter RJ; Perdue JF
Endocrinology; 1987 Aug; 121(2):449-58. PubMed ID: 2439316
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of a fetal somatomedin from the sheep: similarity to insulin-like growth factor II.
Hey AW; Browne CA; Thorburn GD
Endocrinology; 1988 Jan; 122(1):12-21. PubMed ID: 3335201
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of binding subunits of the human 150K insulin-like growth factor binding protein.
Gelato MC; Gaynes LA; Greenstein LA; Nissley SP
J Clin Endocrinol Metab; 1990 Apr; 70(4):879-87. PubMed ID: 1690749
[TBL] [Abstract][Full Text] [Related]
14. O-glycosylation of insulin-like growth factor (IGF) binding protein-6 maintains high IGF-II binding affinity by decreasing binding to glycosaminoglycans and susceptibility to proteolysis.
Marinaro JA; Neumann GM; Russo VC; Leeding KS; Bach LA
Eur J Biochem; 2000 Sep; 267(17):5378-86. PubMed ID: 10951195
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis and processing of the type II insulin-like growth factor receptor in H-35 hepatoma cells.
MacDonald RG; Czech MP
J Biol Chem; 1985 Sep; 260(20):11357-65. PubMed ID: 2993308
[TBL] [Abstract][Full Text] [Related]
16. Rat PC12 pheochromocytoma cells synthesize insulin-like growth factor-binding protein-6.
Bach LA; Tseng LY; Swartz JE; Rechler MM
Endocrinology; 1993 Sep; 133(3):990-5. PubMed ID: 7689963
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of insulin-like growth factor (IGF)-I and IGF-II on the expression of IGF binding proteins (IGFBPs) in a rat neuroblastoma cell line: isolation and characterization of two forms of IGFBP-4.
Ceda GP; Fielder PJ; Henzel WJ; Louie A; Donovan SM; Hoffman AR; Rosenfeld RG
Endocrinology; 1991 Jun; 128(6):2815-24. PubMed ID: 1709857
[TBL] [Abstract][Full Text] [Related]
18. Isolation from human cerebrospinal fluid of a new insulin-like growth factor-binding protein with a selective affinity for IGF-II.
Roghani M; Hossenlopp P; Lepage P; Balland A; Binoux M
FEBS Lett; 1989 Sep; 255(2):253-8. PubMed ID: 2551732
[TBL] [Abstract][Full Text] [Related]
19. Isolation and partial characterization of six somatomedin-like peptides from human plasma Cohn fraction IV.
Blum WF; Ranke MB; Bierich JR
Acta Endocrinol (Copenh); 1986 Feb; 111(2):271-84. PubMed ID: 3953237
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of three molecular forms of insulin-like growth factor II from human Cohn paste IV.
Straczek J; Heulin MH; Chenut AM; Lasbennes A; Geschier C; Belleville F; Nabet P
J Chromatogr; 1990 Nov; 532(2):237-48. PubMed ID: 2084122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
